Increased serum progesterone and estradiol correlate to increased COX-2 tissue expression in cervical intraepithelial neoplasia

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1217-1222

  Samir, Raghad ^a,b   Tot, Tibor ^a   Asplund, Anna ^c   Pekar, Gyula ^a   Hellberg, Dan ^b,c  

^a FALUN HOSPITAL   (Sweden)

^b Center for Clinical Research   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Biological markers; Cervical intraepithelal neoplasia; Cervical squamous epithelium; Estradiol; Progesterone

Indexed keywords

CD4 ANTIBODY; CYCLOOXYGENASE 2; CYTOKERATIN 10; EPIDERMAL GROWTH FACTOR; ESTRADIOL; FRAGILE HISTIDINE TRIAD PROTEIN; INTERLEUKIN 10 ANTIBODY; MONOCLONAL ANTIBODY KI 67; PROGESTERONE; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; UVOMORULIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLOOXYGENASE 2; ESTRADIOL; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PROGESTERONE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77953755893     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Cenci M, Pisani T, French D, Alderisio M and Vecchione A: pRb2/p130, p107 and p53 expression in precancerous lesions and squamous cell carcinoma of the uterine cervix. Anticancer Res 25: 2187-2192, 2005. (Pubitemid 40904621)
2. Van Niekerk D, Guillaud M, Matisec J, Benedet JL, Freeberg JA, Follen M and MacAulay C: p16 and MIB1 improve the sensitivity and specificity of the diagnosis of high grade squamous intraepithelial lesions: Methodological issues in a report of 447 biopsies with consensus diagnosis and HPV HCII testing. Gynecol Oncol 707: S233-S240, 2007.
3. Nam EJ, Kim JW, Kim SW, Kim YT, Kim JH, Yoon BS, Cho NH and Kim S: The expressions of the Rb pathway in cervical intraepithelial neoplasia; predicitive and prognostic significance. Gynecol Oncol 704: 207-211, 2007.
4. Hellberg D, Valentin J and Nilsson S: Long-term use of oral contraceptives and cervical neoplasia: an association confounded by other risk factors. Contraception 32: 337-346, 1985.
5. Castellsaque X and Munoz N: Cofactors in human papillomavirus carcinogenesis - role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monographs 31: 20-28, 2003.
6. Chan W-K, Klock G and Bernard H-U: Progesterone and glucocorticoid elements occur in the long control regions of several human papillomaviruses invloved in anogenital neoplasia. J Virol 63: 3261-3269, 1989. (Pubitemid 19181382)
7. Mitrani-Rosenbaum S, Tsivieli R and Tur-Kaspa R: Oestrogen stimulates differential transcription of human papillomavirus type 16 in SiHa cervical carcinoma cells. J Gen Virol 70: 2227-2232, 1989. (Pubitemid 19215129)
8. Pater A, Bayatpour M and Pater MM: Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives. Am J Obstet Gynecol 162: 1099-1103, 1990. (Pubitemid 20155440)
9. Yuan F, Auborn K and James C: Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone. Cancer Invest 77: 19-29, 1999. (Pubitemid 29072675)
10. Webster K, Taylor A and Gaston K: Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. J Gen Virol 82: 201-213, 2001. (Pubitemid 32045809)
11. Salazar EL, Mercado E, Sojo I and Salcedo M: Relationship between estradiol 16α-hydroxylation and human papillomavirus infection in cervical cell transformation. Gynecol Endocrinol 75: 335-340, 2001. (Pubitemid 33096056)
12. Gorodeski GI: Estrogen attenuates p2X7-R-mediated apoptosis of uterine cervical cells by blocking calcium influx. Nucleosides Nucleotides Nucl Acids 23: 1287-1293, 2004.
13. Hellberg D, Lindström AK and Stendahl U: Correlation between serum estradiol/progesterone ratio and survival length in invasive squamous cell cervical cancer. Anticancer Res 25: 611-616, 2005. (Pubitemid 40470071)
14. Lindström A, Backström T, Hellberg D, Tribukait B, Strang P and Stendahl U: Correlations between serum progesterone and smoking, and the growth fraction of cervical squamous cell carcinoma. Anticancer Res 20: 3637-3640, 2000. (Pubitemid 32002252)
15. Lindström AK, Ulf Stendahl U, Tot T and Hellberg D: Associations between ten biological rumor markers in squamous cell cervical cancer and serum estradiol, serum progesterone and smoking. Anticancer Res 27: 1401-1406, 2007. (Pubitemid 46807215)
16. Uhlen M and Ponten F: Antibody-based proteomics for human tissue profiling. Mol Cell Proteomics 4: 384-393, 2005.
17. Tervahautu A, Syrjänen S and Syrjänen K: Epidermal growth factor receptor, c-erbB-2 proto-oncogene and estrogen receptor expression in human apillomavirus lesions of the uterine cervix. Int J Gynecol Pathol 13: 234-240, 1994.
18. Boiko IV, Mitchell MF, Hu W, Pandey DK, Mathevet P, Malpica A and Hittelman WN: Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an α- difluoromethyllornithine chemoprevention trial. Clin Cancer Res 4: 1383-1391, 1998.
19. INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer. J Clin Pathol 58: 525-534, 2005.
20. Terry G, Ho L, Londesborough P, Cross P, Lopes A, Monagham J and Cuzick: The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. Br J Cancer 97: 2056-2062, 2004.
21. Martin CM, Astbury CM and O'Leary JJ: Molecular profiling of cervical neoplasia. Expert Rev Mol Diagn 6: 217-229, 2006.
22. Hofseth LJ, Hussain SP and Harris CC: p53: 25 years after its discovery. Trends Pharm Sci 25: 177-181, 2004.
23. Young JL, Jazaeri AA, Darus CJ and Modesitt SC: Cyclooxygenase-2 in cervical neoplasia: A review. Gynecol Oncol 109: 140-145, 2008.
24. Lindström AK, Stendahl U, Tot T, Lidström BM and Hellberg D: Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expression. Anticancer Res 27: 1609-1616, 2007.
25. Azar KK, Tani M, Yasuda H, Sakai A, Inoue M and Sasagawa T: Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol 35: 1376-1384, 2004.
26. Bermudez-Morales VH, Gutierrez LX, Alcocer-Gonzalez JM, Burguete A and Madrid-Marina V: Correlation between IL-10 gene expression and HPV infection in cervical cancer: A mechanism for immune response escape. Cancer Invest 26: 1037-1043, 2008.
27. Eiben GL, Velders MP and Kast WM: The cell-mediated immune response to human papilloma-induced cervical cancer: Implications for immunotherapy. Adv Cancer Res 86: 113-148, 2002.
28. Brabin L: Interactions of the female hormonal environment, susceptibility to viral infections and disease progression. AIDS Patient Care 16: 211-221, 2002.
29. De Villiers E-M: Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 103: 705-708, 2003.
30. Elson DA, Riley RR, Lacey A, Thordarson G, Talamantes FJ and Arbeit JM: Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis. Cancer Res 60: 1267-1275, 2000. (Pubitemid 30151994)